#Neuralink
-
Musk’s Neuralink Aims for 20,000 Chip Implants Annually, Unveils Three Device Types
Neuralink, Elon Musk’s brain-computer interface company, plans a major expansion, aiming to implant BCI chips in 20,000 patients annually by 2031, generating $1 billion in revenue. The company intends to establish five clinics in six years, developing “Telepathy,” “Blindsight,” and “Deep” implants for communication, vision restoration, and neurological disorder treatment. US approval for “Telepathy” is expected by 2029, with “Blindsight” launching in 2030. Neuralink, valued at $9 billion, has secured $1.3 billion in funding.
